175 related articles for article (PubMed ID: 19023100)
1. Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes.
Inaba S; Iwai M; Tomono Y; Senba I; Furuno M; Kanno H; Okayama H; Mogi M; Higaki J; Horiuchi M
Stroke; 2009 Feb; 40(2):597-603. PubMed ID: 19023100
[TBL] [Abstract][Full Text] [Related]
2. Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice.
Inaba S; Iwai M; Furuno M; Tomono Y; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
Hypertension; 2009 Feb; 53(2):356-62. PubMed ID: 19047580
[TBL] [Abstract][Full Text] [Related]
3. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.
Iwai M; Liu HW; Chen R; Ide A; Okamoto S; Hata R; Sakanaka M; Shiuchi T; Horiuchi M
Circulation; 2004 Aug; 110(7):843-8. PubMed ID: 15289370
[TBL] [Abstract][Full Text] [Related]
4. Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density.
Li JM; Mogi M; Iwanami J; Min LJ; Tsukuda K; Sakata A; Fujita T; Iwai M; Horiuchi M
Stroke; 2008 Jul; 39(7):2029-36. PubMed ID: 18436887
[TBL] [Abstract][Full Text] [Related]
5. Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage.
Min LJ; Mogi M; Tsukuda K; Jing F; Ohshima K; Nakaoka H; Kan-No H; Wang XL; Chisaka T; Bai HY; Iwanami J; Horiuchi M
Am J Hypertens; 2014 Aug; 27(8):1036-44. PubMed ID: 24572705
[TBL] [Abstract][Full Text] [Related]
6. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.
Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M
J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice.
Iwai M; Inaba S; Tomono Y; Kanno H; Iwanami J; Mogi M; Horiuchi M
Hypertens Res; 2008 Jan; 31(1):161-8. PubMed ID: 18360031
[TBL] [Abstract][Full Text] [Related]
8. Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.
Hamai M; Iwai M; Ide A; Tomochika H; Tomono Y; Mogi M; Horiuchi M
Neuropharmacology; 2006 Sep; 51(4):822-8. PubMed ID: 16824557
[TBL] [Abstract][Full Text] [Related]
9. Temporary treatment with AT1 receptor blocker, valsartan, from early stage of hypertension prevented vascular remodeling.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
Am J Hypertens; 2011 May; 24(5):550-6. PubMed ID: 21293390
[TBL] [Abstract][Full Text] [Related]
10. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
[TBL] [Abstract][Full Text] [Related]
11. Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice.
Chen S; Li G; Zhang W; Wang J; Sigmund CD; Olson JE; Chen Y
Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1526-31. PubMed ID: 19759335
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.
Iwanami J; Mogi M; Tsukuda K; Wang XL; Nakaoka H; Ohshima K; Chisaka T; Bai HY; Kanno H; Min LJ; Horiuchi M
Hypertens Res; 2014 Jul; 37(7):616-20. PubMed ID: 24599018
[TBL] [Abstract][Full Text] [Related]
13. Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats.
Stenman E; Edvinsson L
Stroke; 2004 Apr; 35(4):970-4. PubMed ID: 15001791
[TBL] [Abstract][Full Text] [Related]
14. Larger anastomoses in angiotensinogen-knockout mice attenuate early metabolic disturbances after middle cerebral artery occlusion.
Maeda K; Hata R; Bader M; Walther T; Hossmann KA
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1092-8. PubMed ID: 10532633
[TBL] [Abstract][Full Text] [Related]
15. Neuronal over-expression of ACE2 protects brain from ischemia-induced damage.
Chen J; Zhao Y; Chen S; Wang J; Xiao X; Ma X; Penchikala M; Xia H; Lazartigues E; Zhao B; Chen Y
Neuropharmacology; 2014 Apr; 79():550-8. PubMed ID: 24440367
[TBL] [Abstract][Full Text] [Related]
16. Differential roles of renin and angiotensinogen in the feto-maternal interface in the development of complications of pregnancy.
Takimoto-Ohnishi E; Saito T; Ishida J; Ohnishi J; Sugiyama F; Yagami K; Fukamizu A
Mol Endocrinol; 2005 May; 19(5):1361-72. PubMed ID: 15695374
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia.
Fu H; Hosomi N; Pelisch N; Nakano D; Liu G; Ueno M; Miki T; Masugata H; Sueda Y; Itano T; Matsumoto M; Nishiyama A; Kohno M
J Hypertens; 2011 Nov; 29(11):2210-9. PubMed ID: 21934531
[TBL] [Abstract][Full Text] [Related]
18. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
[TBL] [Abstract][Full Text] [Related]
19. Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice.
Mogi M; Iwai M; Chen R; Iwanami J; Ide A; Tsukuda K; Yoshii T; Horiuchi M
Am J Hypertens; 2006 Nov; 19(11):1144-9. PubMed ID: 17070425
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
